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DATA MINING OF SEQUENCES STORED IN PUBLIC DATABASES IS
A USEFUL TOOL TO IDENTIFY GENES INVOLVED IN OA PATHOGENESIS
O. Martínez de Ilarduya Ruiz, F.J. Blanco. INIBIC-CHUAC, CIBER-BBN/ISCIII, A
Coruña, Spain
Purpose: In the early days of gene expression studies, a common method
was random sequencing of clones derived from cDNA libraries and anno-
tation of the resulting expressed sequence tags (EST). As a result, more
than eight million human cDNA sequences resulting from short single-
pass sequencing reads from a wide variety of tissues and conditions are
stored in the NCBI database. Among them, several thousands correspond
to healthy (HC) or osteoarthritic (OAC) cartilage. It means a wealth of
useful data largely underused. Appropriate analysis using current bio-
informatic tools could help to identify genes relevant for the pathophysi-
ology of osteoarthrosis, as well as the normal homeostasis of healthy
cartilage.
Methods: dbEST division of GenBank was searched for data corresponding
to human normal or OA cartilage. The matching genes were identiﬁed
using the Blast suite. Both data sets were compared to detect differentially
expressed genes. A minimum level of expression of 0.6% (corresponding to
presence of at least 3 transcripts in only one sample) was used as cutoff to
assign speciﬁc expression in one of the conditions. Further analyses using
Reactome and KEGG tools were used to identify biological processes and
functions.
Results: 5224 and 5019 sequences were identiﬁed as unmistakably
derived from HC or OA cartilage, respectively. After removing vector
sequences or too short cDNAs, we selected 4722 HC and 4621 OAC EST,
matching to 2384 or 2009 known sequences, respectively. Among them,
1747 (73.3%) and 1465 (72.9%) genes, respectively, were represented by
a single transcript, showing great diversity and suggesting that deeper
coverage of the libraries is still possible. The identiﬁed transcripts included
known nuclear and mitochondrial genes, as well as previously unanno-
tated chromosomic regions, probably corresponding to non-coding genes.
Themost abundant transcripts in both sets of samples included DCN, GPX3,
CLU or VIM. Remarkably, very few collagen-derived transcripts were
identiﬁed, possibly due to the fact that they are stable proteins with very
low turnover rate. Selection of differentially expressed genes produced
a list of 101 and 91 genes that are preferentially expressed in HC and OAC,
respectively, including mitochondrial and non-coding genes. Some of
them code for already knownmarkers of cartilage damage, (COMP, CRTAC1,
CTGF.) or cartilage integrity (EGR1) while some have not been previously
associated with cartilage damage or protection. Among genes overex-
pressed in HC we found DPP10, CSDA and the ribosomal proteins RPL11 and
RPL41. Genes overexpressed in OAC included the candidate suppressor
gene GLTSCR2, RAB5B or the ribosomal proteins RPS6 and RPS9. Pathway
analysis revealed that genes involved in nicotinate and nicotinamide
metabolism were overrepresented in the HC samples, while genes
involved in glycolysis and aminoacid metabolism appeared overexpressed
in transcripts from OAC.
Conclusions: Data mining of sequences stored in public databases can be
a useful tool to identify genes involved in biological process. We have been
able to identify a series of genes differentially expressed in normal and OA
cartilage. Gene expression experiments will be carried out to conﬁrm these
results in clinical samples and to identify possible interacting factors.
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SALMON CALCITONIN INHIBITED CHONDROCYTE HYPERTROPHY EX
VIVO
P. Chen-An, N. Hansen, Y. He, K.W. Andreassen, K. Henriksen, M.A.
Karsdal, A.-C. Bay-Jensen. Nordic BioSci. A/S, Herlev, Denmark
Purpose: Chondrocyte hypertrophic-differentiation, leading to cartilage
calciﬁcation and sclerosis of subchondral bone, is a key event of the early
OA. An ideal agent for OA treatment should be able to affect both
remodeling of subchondral bone and prevention or regeneration of artic-
ular cartilage. The growing evidence indicates that hypertrophic chon-
drocytes represent a potential target for OA treatment. We have shown
previously that salmon calcitonin could prevent chondrocyte hypertrophywhich was induced by triiodo-L-thyronine (T3). In this study, we aim to
investigate whether salmon calcitonin could inhibit or reverse the chon-
drocyte hypertrophic-differentiation and calciﬁcation of cartilage, to ﬁnd
the evident that calcitonin could be an ideal agent for OA treatment.
Methods: Full depth cartilage (FDC) explants (from superﬁcial to calciﬁed
cartilage) were isolated from bovine femoral condyle and hypertrophy was
induced by culture for 4 days with triiodo-L-thyronine (T3) stimulation.
Non-stimulated explants were cultured as control. Doses of sCT ranged
from 1nM to 100nM were added from day 4 to day 13 without continuous
T3 stimulation. Explants without sCT treatment from day 4were presented
as W/O. Cartilage turnover was measured by biochemical markers of type
II collagen (COL II) formation (PIINP assay) and degradation (CIIM assay).
A sandwich ELISA assay - AGNx-II was used for measuring aggreacan
degradation. Cartilage calciﬁcation was measured as alkaline phosphatase
(ALP) activity by pNPP assay. As markers of hypertrophic chondrocytes,
Indian hedgehog (IHH), COL X, matrix metallopeptidase 13 (MMP-13) and
ALPwere evaluated using RT-PCR.
Results: Hypertrophy was induced by 4 days stimulation with T3. Signif-
icant increased expression was found in all four hypertrophic markers
(p<0.05). At day 8, sCT increased cartilage formation, and decreased
cartilage degradation and calciﬁcation dose-dependently, comparing with
W/O (p<0.001). On the contrary, sCT increased aggrecan degradation
slightly in a dose-dependent manner. Chondrocyte kept hypertrophic-
differentiation without T3 (W/O). Dosis of sCT inhibited MMP13 and ALP
expression, in which 10nM inhibited MMP13 signiﬁcantly (p<0.001). In
contrast, only 100nM sCT suppresses IHH (P<0.05) and COL X expression.
At day 13, sCT increased cartilage formation and decreased calciﬁcation
dose-dependently, comparing with W/O (p<0.01). Interestingly, sCT
decreased aggrecan degradation slightly in a dose-dependent manner at
day 13. Chondrocyte continued hypertrophic-differentiation without T3
stimulation at day 13 (W/O). Dosis of sCT inhibited gene expression of all
four hypertrophic molecular markers in which10nM sCT decreased IHH
andMMP13 expression signiﬁcantly (p<0.001), and the level of IHH, COL X
and MMP13 was lower than control.
Conclusions: The outcome suggests that T3 induced hypertrophic chon-
drocytes at day4, and chondrocyte continued hypertrophic-differentiation
after 4 days without T3. sCT inhibited expression of markers of hypertro-
phic chondrocytes and cartilage degradation at day 8, and could reverse
chondrocyte hypertrophic-differentiation at day 13, in which10nM sCT is
the most promising. Our investigation provides useful information on the
efﬁcacy of salmon calcitonin on hypertrophic chondrocytes and promising
effect for OA treatment.
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CHANGES IN HTRA1 IN CARTILAGE AFTER SINGLE IMPACT LOADING
P. Hernandez, J. Wardale, N. Rushton, F. Henson. Univ. of Cambridge,
Cambridge, United Kingdom
Purpose: The serine protease HtrA1 has been demonstrated to be
increased in osteoarthritic cartilage in both naturally occuring disease and
animal models, however little is known of the control of HtrA1 in cartilage.
In order to begin to identify key events in the control of HtrA1 in response
to challenge, we have investigated the levels of HtrA1 in cartilage explants
from human and horse following Single Impact Loading (SIL), a model for
early OA.
Methods: Full thickness cartilage discs were cultured in 5% CO2 and 20%O2
in DMEM + 10% FCS for up to 7 days (n¼16). Control samples were not
loaded, experimental samples were SIL with 500g from 2.5cm (8MPs).
HtrA1 distribution in cartilage samples was investigated using immuno-
histochemistry, total levels of HtrA1 were quantiﬁed by Western blotting
and densitometry and HtrA1 RNA levels were measured using qPCR with
speciﬁcally designed equine primers.
Results: HtrA1 was demonstrated to increase throughout the cartilage
sections following SIL and subsequent culture, in contrast to being
conﬁned to the superﬁcial zone in control cartilage. Suprisingly, in control
cartilage, western blotting revealed an oscillatory pattern of HtrA1 protein
production, with an approximate ‘cycle time’ of 72 hours. This result was
demonstrable in human and horse cartilage and was repeatable in all
samples studied. Moreover, after SIL this protein pattern did not change
